S2Medical AB (publ)'s latest marketcap:
As of 07/05/2025, S2Medical AB (publ)'s market capitalization has reached $1.1 M. According to our data, S2Medical AB (publ) is the 47644th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.1 M |
| Revenue (ttm) | 1.53 M |
| Net Income (ttm) | 501,340.38 |
| Shares Out | 844.26 M |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/21/2025 |
S2Medical AB (publ)'s yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | kr1.1 M | 18.1% | 47644 |
| 12/30/2024 | kr8.86 M | -46.36% | 44567 |
| 12/29/2023 | kr16.53 M | -25.2% | 42050 |
| 12/30/2022 | kr22.09 M | -72.04% | 40143 |
| 12/30/2021 | kr79.02 M | -12.55% | 35984 |
| 12/30/2020 | kr90.36 M | -15.61% | 31834 |
| 12/30/2019 | kr107.08 M | -68.92% | 28460 |
| 12/28/2018 | kr344.5 M | 22338 |
Company Profile
About S2Medical AB (publ)
S2Medical AB (publ) is a Swedish company specializing in the development, production, and sale of advanced wound healing products for burns and chronic wounds.
Product Offerings
- Epiprotect 2117: A synthetic allograft/xenograft substitute designed for wound care.
- Epiprotect Ulcer: A biosynthetic cellulose polymer film used as a protective barrier for superficial and deep wounds, including pre-surgical coverage.
- INSTABIND: Washable, durable, waterproof, and self-adhesive bandages for versatile wound management.
- NO SMELL: A perfume-free odor remover for wound care hygiene.
- Silverlon Dressings: Advanced dressings that deliver silver ions to promote healing.
- BIOPAD & BIOSPRAY: A soft sponge (BIOPAD) and sprayable medication powder (BIOSPRAY) for wound treatment.
Additional Services
The company operates S2Clinic, a specialized wound healing center dedicated to advanced care solutions.
Company Background
Founded in 2013, S2Medical AB is headquartered in Linköping, Sweden, and continues to innovate in the field of wound care.
Frequently Asked Questions
-
What is S2Medical AB (publ)'s (STO-S2M) current market cap?As of 07/05/2025, S2Medical AB (publ) (including the parent company, if applicable) has an estimated market capitalization of $1.1 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does S2Medical AB (publ) (STO-S2M) rank globally by market cap?S2Medical AB (publ) global market capitalization ranking is approximately 47644 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.